Companies: 10,795·Total market cap: $144.5T
Molecular Partners AG

Molecular Partners AG

MOLNNASDAQHealthcare● Active
$3.95
$-0.15(-3.66%)
Market Cap$148168932
P/E Ratio
52W High$5.36
52W Low$3.41
Overview

Molecular Partners AG(MOLN)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

moln · 股价预测 · 4 位分析师(近3月)· FMP · 更新于 2026年6月9日

分析师评级与共识

基于过去 3 个月内 4 位华尔街分析师

SellBuy

Hold

4 位分析师

共识

评级分布

Strong Buy
0
Buy
1
Hold
3
Sell
0
Strong Sell
0
合计: 4 · 买入占比: 25.0%

12 个月目标价

High

$13.00

Consensus

$13.00

+229.1% upside

Low

$13.00

Median: $13 · Last Close: $3.95

Molecular Partners AG(MOLN)的分析师共识为 Hold,基于过去 3 个月内 4 位华尔街分析师的评级。MOLN 的 12 个月平均目标价为 $13.00,相对当前价 $3.95 代表 +229.1% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足,无法为该股票生成预测图表。

短期股价预测

Bear

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-10$3.970.40%

1-day model range: $3.93–$4. Peak: $4 (+0.40%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$2-41.2%
2028$2-53.3%
2029$2-58.1%
2030$2-60.3%
2031-61.3%
Confidence:Medium

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

BEARISH

Based on 14 technical indicators

0%7%93%
0Buy
1Neutral
13Sell
RSI (14)54.4Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · MOLN · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$3.99SELL
MA 10$4.02SELL
MA 20$3.96SELL
MA 50$4.11SELL
MA 100$4.34SELL
MA 200$4.16SELL
Current $MOLN · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$4.00SELL
EMA 10$4.00SELL
EMA 20$4.02SELL
EMA 50$4.13SELL
EMA 100$4.21SELL
EMA 200$4.23SELL
Current $MOLN · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
HC Wainwright & Co.2026-04-22
Maintains
BuyBuy
HC Wainwright & Co.2026-03-16
Maintains
BuyBuy
JP Morgan2025-12-08
Maintains
NeutralNeutral
JP Morgan2025-09-03
Maintains
NeutralNeutral
JP Morgan2023-12-05
Maintains
NeutralNeutral
SVB Leerink2022-08-29
Downgrade ↓
OutperformMarket Perform
Credit Suisse2022-05-25
Upgrade ↑
UnderperformNeutral
SVB Leerink2022-04-27
Maintains
OutperformOutperform
SVB Leerink2022-01-14
Maintains
OutperformOutperform
SVB Leerink2021-08-27
Maintains
OutperformOutperform

Wall Street analysts have recently issued updated ratings on Molecular Partners AG (MOLN) stock. Of the recent 10 rating actions, 1 were upgrades and 1 were downgrades. 4 analysts currently cover MOLN.

分析师推荐趋势

Buy ratings01↑ +1
Hold ratings101
Sell ratings00

MOLN analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$6M

↑ 343.4% YoY

Revenue Next Year

$31M

↑ 459.1% YoY

EPS This Year

$-1.31

EPS Next Year

$-0.93

↓ 29.0% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast MOLN EPS of $-1.31 for the current fiscal year, based on estimates from 2 analysts. The MOLN revenue forecast is $6M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

MOLN 股价预测由两类独立数据源支撑:来自 4 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。MOLN 的共识目标价为 $13.00(+229.1% 上行空间),分析师共识为 Hold。

MOLN 的短期预测(明日)为 $3.97(+0.40%)。 MOLN 对 2027 年的股价预测均值为 $2。 MOLN 对 2030 年的预测区间为 $1–$2。

Molecular Partners AG 在 NASDAQ 上市,代码 MOLN。MOLN 在 2027 年的整体展望偏中性/分化,在覆盖分析师中约 25% 对应 Hold 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

MOLN 预测 · 8 个问题

根据 4 位华尔街分析师,MOLN 的 12 个月平均目标价为 $13.00,最高 $13.00、最低 $13.00。若有图表,中位目标价可在上方查看。相对当前价 $3.95,隐含约 +229.1% 的上行空间。

MOLN 目标价MOLN 分析师目标价MOLN 12个月目标价目标价 MOLN

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.